U.S. Pharma Stock News

ON Semiconductor recently announced that Simon Keeton, Group President of its Power Solutions Group, will resign from all roles effective June 30, 2026, after stepping down from officer positions immediately but staying on to support a leadership handover. This transition affects a core business focused on energy-efficient and automotive power applications, raising questions about continuity in an area central to ON Semiconductor’s long-term positioning. We’ll now examine how Keeton’s...

Wondering if V.F at around US$16.36 is a bargain or a value trap right now? This article walks through what the current price might actually imply about the company. The stock has been under pressure recently, with a 7 day return of a 12.6% decline, a 30 day return of a 22.5% decline and a 5 year return of a 75.3% decline. This naturally raises questions about risk, sentiment and where value might now sit. Recent coverage has focused on V.F's position in the consumer durables space and how...

Gulfport Energy (GPOR) is in focus after CEO and president John Reinhart resigned with immediate effect. The board has installed an interim Office of the Chairman and begun a formal chief executive search. See our latest analysis for Gulfport Energy. The leadership shake up comes after a softer patch for the shares, with a 7 day share price return of a 6.69% decline and a 30 day share price return of a 5.54% decline. This contrasts with the 1 year total shareholder return of 17.99% and the 3...

Earlier in March 2026, Citi Research upgraded Werner Enterprises from a Sell to a Neutral rating, citing improved valuations despite weak freight demand and highlighting the company’s sector resilience and diversified transport and logistics offerings. The upgrade arrives as Werner celebrates its 70th anniversary and emphasizes its cross-border Mexico operations, technology platform Werner EDGE, and broader multi-modal service mix as foundations for its role in the global supply chain. We’ll...

Celldex Therapeutics recently presented new and additional positive Phase 2 and open-label extension data on its antibody barzolvolimab in chronic inducible urticaria subtypes at the 2026 AAAAI Annual Meeting, showing rapid improvements in urticaria control on both initial and repeat treatment. A key insight from these results is that many patients who initially achieved complete response in cold urticaria or symptomatic dermographism regained similar disease control after retreatment,...

Event overview and recent price context Tronox Holdings (TROX) has drawn attention after recent share price volatility, with the stock down about 10% over the past month but up roughly 43% in the past 3 months. For investors, that mix of short term weakness and stronger recent momentum raises questions about how the current US$6.76 share price lines up with Tronox Holdings' value score of 4 and its reported financial profile. See our latest analysis for Tronox Holdings. Looking beyond the...

CRISPR Therapeutics (CRSP) has completed a private offering of US$550 million in convertible senior notes due 2031, upsized from an initially announced US$350 million, drawing investor attention to its funding mix. See our latest analysis for CRISPR Therapeutics. The financing news has arrived during a weak patch for the shares, with a 1-day share price return showing a 5.44% decline and a 7-day share price return showing a 16.78% decline. This comes even as the 1-year total shareholder...

Citigroup (C) has been in focus after management expressed confidence in hitting a 10% to 11% ROTCE target and outlined expectations for mid-teens growth in markets and investment banking fees. See our latest analysis for Citigroup. The recent guidance on ROTCE and fee growth comes after a softer patch in the share price, with a 30 day share price return of an 11.78% decline and a year to date share price return of an 8.01% decline, set against a 1 year total shareholder return of 64.87% and...

If you are wondering whether International Business Machines (IBM) still offers value at around US$248.87 per share, you are not alone. This article will help you frame that question clearly. The stock has slipped about 0.5% over the last week and 16.0% over the last month, while still showing a 2.2% return over 1 year and a very large gain over 3 and 5 years. Recent headlines have focused on IBM's positioning as a major software and services player, with investors reassessing how its mix of...

If you are wondering whether Occidental Petroleum's current share price reflects its true worth, this article walks through the key numbers so you can judge the value story for yourself. The stock last closed at US$55.58, with returns of 3.7% over 7 days, 19.1% over 30 days, 31.1% year to date, 23.2% over 1 year, 3.0% over 3 years and 104.0% over 5 years, which gives plenty of context before you weigh up what feels like a fair price today. Recent coverage around Occidental Petroleum has...

Ichor Holdings (ICHR) was caught in a sector wide sell off after a regulatory penalty hit a major semiconductor player, and potential new US export controls on AI chips raised risk perceptions for equipment suppliers. See our latest analysis for Ichor Holdings. Despite the recent sector driven pullback, Ichor Holdings still carries strong momentum, with a 30 day share price return of 31.43% and a 90 day share price return of 139.86%, while the 1 year total shareholder return sits at...

Kingsoft Cloud Holdings recently confirmed that its share capital structure stayed unchanged in February 2026 and that it continues to meet Hong Kong’s public float requirements, while also preparing to release its unaudited fourth-quarter and full-year 2025 results, which were later published on 25 March 2025 alongside an earnings call and webcast. At the same time, the company has been highlighted for its exposure to artificial intelligence and intelligent cloud services within the Xiaomi...

Cintas, ticker NasdaqGS:CTAS, has entered into a definitive agreement to acquire UniFirst in a cash and stock transaction. The deal combines two major uniform and facility services providers in North America, creating a much larger player in this market. The transaction is expected to create significant scale benefits and cost efficiencies across operations and service offerings. Cintas focuses on uniform rental, facility services, and related business solutions across North America, and...

Sify Technologies (SIFY) has caught investor attention after recent share price swings, set against a mixed performance record where past year total return, multi year returns, and more recent moves tell different stories. See our latest analysis for Sify Technologies. Recent trading has cooled slightly, with a 1 day share price return of 1.39% decline and a 7 day share price return of 3.72% decline, but the 90 day share price return of 24.52% and 1 year total shareholder return of 201.27%...

Understanding Interparfums after recent share performance Interparfums (IPAR) has seen mixed recent returns, with the stock down around 6% over the past month but up roughly 13% in the past 3 months. This has prompted fresh interest in its fragrance focused business. See our latest analysis for Interparfums. Looking beyond the recent 6% 30 day share price pullback, Interparfums still has a 13.4% 90 day share price return, although the 1 year total shareholder return of a 25% decline shows...

Valvoline (NYSE:VVV) has launched the Happy to Help Fund in partnership with Blue Grass Community Foundation to back mental and physical well-being projects for children and youth in Lexington. The company has named Jordan M. Denny as Chief Accounting Officer and Controller, marking a key update to its executive leadership team. For you as an investor, this pairs a fresh community initiative with a leadership change at a company best known for vehicle lubricants, services, and related...

If you are wondering whether Huntington Ingalls Industries' current share price still offers value, you are not alone. This article is designed to unpack that question clearly. The stock recently closed at US$413.70, with a 7 day return of a 5.3% decline, a 30 day return of 1.9%, a 1 year return of 119.8%, a 3 year return of 114.8% and a 5 year return of 133.3%. Recent attention on Huntington Ingalls Industries has been influenced by ongoing contract activity and investor interest in U.S...

In March 2026, FormFactor, Inc. launched the Flatiron Dilution Refrigerator, a compact horizontal benchtop system that delivers ~30 mK performance, faster sample access, and integrated optical windows to streamline sub-kelvin optical and electrical measurements for quantum device research and industrial development. By shrinking millikelvin experimentation into an ergonomic, lab-ready platform that supports frequent thermal cycling, Flatiron aims to ease a key testing bottleneck for quantum...

In recent weeks, Prologis has featured prominently at multiple investor and industry conferences and received renewed analyst coverage highlighting its global logistics platform and growing data center and renewable energy offerings. Institutional investors and research firms have emphasized how Prologis’s expansion into data centers and its China-listed REIT deepen its reach into high-barrier, growth-oriented logistics markets. We’ll now examine how Prologis’s push into data centers and...

Antero Midstream (AM) has been in focus after reporting fourth quarter 2025 earnings per share above analyst expectations, while revenue lagged projections, and after closing a $400 million sale of its Utica Shale midstream assets. See our latest analysis for Antero Midstream. Those earnings and asset sale headlines have come alongside strong share price momentum, with a 17.12% 1 month share price return, 28.87% year to date share price return, and a very large 5 year total shareholder return...

Super Group (SGHC) recently reported its Q4 results, highlighting record customer numbers, rising deposits, the completion of a major African tech migration, and the launch of its ZAR Supercoin in South Africa. The company also returned US$156 million to shareholders and raised its quarterly dividend target, underlining a stronger focus on capital returns alongside product innovation. Next, we’ll examine how the Q4 earnings update and increased dividend plans could influence Super Group’s...

Krystal Biotech (KRYS) is in focus after reporting fourth quarter 2025 results that topped analyst expectations on both earnings per share and revenue, alongside a significant stock sale by its President and CEO. See our latest analysis for Krystal Biotech. Despite the Q4 beat, the recent 1 month share price return of -6.46% and 7 day share price return of -3.77% suggest some short term profit taking, while the 1 year total shareholder return of 42.95% and 3 year total shareholder return...

If you are wondering whether Steel Dynamics at around US$184 per share still offers value, this article walks through what the current price might be implying about the business. The stock has had a mixed stretch recently, with a 5.0% decline over the last week and a 9.1% decline over the last month, while still showing returns of 4.7% year to date and 51.3% over the past year, as well as a very large gain over five years. Recent coverage has focused on Steel Dynamics as a major US steel...

Recent share performance and business snapshot Crinetics Pharmaceuticals (CRNX) has drawn investor attention after a weak month for the share price, with the stock showing negative returns over the past month and past 3 months despite a positive 1 year total return. The clinical stage company focuses on rare endocrine diseases, with its lead candidate Paltusotine in Phase 3 trials and several earlier stage programs. This context may influence how investors weigh recent share price moves...